Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype

Chromophobe renal cell carcinoma (chRCC) is a renal tumor subtype with a good prognosis, characterized by multiple chromosomal copy number variations (CNV). The World Health Organization (WHO) chRCC classification guidelines define a classic and an eosinophilic variant. Large cells with reticular cy...

Full description

Saved in:
Bibliographic Details
Published inCancers Vol. 11; no. 10; p. 1492
Main Authors Ohashi, Riuko, Schraml, Peter, Angori, Silvia, Batavia, Aashil A., Rupp, Niels J., Ohe, Chisato, Otsuki, Yoshiro, Kawasaki, Takashi, Kobayashi, Hiroshi, Kobayashi, Kazuhiro, Miyazaki, Tatsuhiko, Shibuya, Hiroyuki, Usuda, Hiroyuki, Umezu, Hajime, Fujishima, Fumiyoshi, Furusato, Bungo, Osakabe, Mitsumasa, Sugai, Tamotsu, Kuroda, Naoto, Tsuzuki, Toyonori, Nagashima, Yoji, Ajioka, Yoichi, Moch, Holger
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 03.10.2019
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Chromophobe renal cell carcinoma (chRCC) is a renal tumor subtype with a good prognosis, characterized by multiple chromosomal copy number variations (CNV). The World Health Organization (WHO) chRCC classification guidelines define a classic and an eosinophilic variant. Large cells with reticular cytoplasm and prominent cell membranes (pale cells) are characteristic for classic chRCC. Classic and eosinophilic variants were defined in 42 Swiss chRCCs, 119 Japanese chRCCs and in whole-slide digital images of 66 chRCCs from the Cancer Genome Atlas (TCGA) kidney chromophobe (KICH) dataset. 32 of 42 (76.2%) Swiss chRCCs, 90 of 119 (75.6%) Japanese chRCCs and 53 of 66 (80.3%) TCGA-KICH were classic chRCCs. There was no survival difference between eosinophilic and classic chRCC in all three cohorts. To identify a genotype/phenotype correlation, we performed a genome-wide CNV analysis using Affymetrix OncoScan® CNV Assay (Affymetrix/Thermo Fisher Scientific, Waltham, MA, USA) in 33 Swiss chRCCs. TCGA-KICH subtypes were compared with TCGA CNV data. In the combined Swiss and TCGA-KICH cohorts, losses of chromosome 1, 2, 6, 10, 13, and 17 were significantly more frequent in classic chRCC (p < 0.05, each), suggesting that classic chRCC are characterized by higher chromosomal instability. This molecular difference justifies the definition of two chRCC variants. Absence of pale cells could be used as main histological criterion to define the eosinophilic variant of chRCC.
AbstractList Chromophobe renal cell carcinoma (chRCC) is a renal tumor subtype with a good prognosis, characterized by multiple chromosomal copy number variations (CNV). The World Health Organization (WHO) chRCC classification guidelines define a classic and an eosinophilic variant. Large cells with reticular cytoplasm and prominent cell membranes (pale cells) are characteristic for classic chRCC. Classic and eosinophilic variants were defined in 42 Swiss chRCCs, 119 Japanese chRCCs and in whole-slide digital images of 66 chRCCs from the Cancer Genome Atlas (TCGA) kidney chromophobe (KICH) dataset. 32 of 42 (76.2%) Swiss chRCCs, 90 of 119 (75.6%) Japanese chRCCs and 53 of 66 (80.3%) TCGA-KICH were classic chRCCs. There was no survival difference between eosinophilic and classic chRCC in all three cohorts. To identify a genotype/phenotype correlation, we performed a genome-wide CNV analysis using Affymetrix OncoScan® CNV Assay (Affymetrix/Thermo Fisher Scientific, Waltham, MA, USA) in 33 Swiss chRCCs. TCGA-KICH subtypes were compared with TCGA CNV data. In the combined Swiss and TCGA-KICH cohorts, losses of chromosome 1, 2, 6, 10, 13, and 17 were significantly more frequent in classic chRCC (p < 0.05, each), suggesting that classic chRCC are characterized by higher chromosomal instability. This molecular difference justifies the definition of two chRCC variants. Absence of pale cells could be used as main histological criterion to define the eosinophilic variant of chRCC.
Chromophobe renal cell carcinoma (chRCC) is a renal tumor subtype with a good prognosis, characterized by multiple chromosomal copy number variations (CNV). The World Health Organization (WHO) chRCC classification guidelines define a classic and an eosinophilic variant. Large cells with reticular cytoplasm and prominent cell membranes (pale cells) are characteristic for classic chRCC. Classic and eosinophilic variants were defined in 42 Swiss chRCCs, 119 Japanese chRCCs and in whole-slide digital images of 66 chRCCs from the Cancer Genome Atlas (TCGA) kidney chromophobe (KICH) dataset. 32 of 42 (76.2%) Swiss chRCCs, 90 of 119 (75.6%) Japanese chRCCs and 53 of 66 (80.3%) TCGA-KICH were classic chRCCs. There was no survival difference between eosinophilic and classic chRCC in all three cohorts. To identify a genotype/phenotype correlation, we performed a genome-wide CNV analysis using Affymetrix OncoScan ® CNV Assay (Affymetrix/Thermo Fisher Scientific, Waltham, MA, USA) in 33 Swiss chRCCs. TCGA-KICH subtypes were compared with TCGA CNV data. In the combined Swiss and TCGA-KICH cohorts, losses of chromosome 1, 2, 6, 10, 13, and 17 were significantly more frequent in classic chRCC ( p < 0.05, each), suggesting that classic chRCC are characterized by higher chromosomal instability. This molecular difference justifies the definition of two chRCC variants. Absence of pale cells could be used as main histological criterion to define the eosinophilic variant of chRCC.
Author Rupp, Niels J.
Schraml, Peter
Miyazaki, Tatsuhiko
Angori, Silvia
Osakabe, Mitsumasa
Kobayashi, Hiroshi
Ohashi, Riuko
Kuroda, Naoto
Nagashima, Yoji
Umezu, Hajime
Kawasaki, Takashi
Kobayashi, Kazuhiro
Shibuya, Hiroyuki
Furusato, Bungo
Batavia, Aashil A.
Ajioka, Yoichi
Tsuzuki, Toyonori
Usuda, Hiroyuki
Otsuki, Yoshiro
Moch, Holger
Fujishima, Fumiyoshi
Ohe, Chisato
Sugai, Tamotsu
AuthorAffiliation 5 Department of Pathology and Laboratory Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan; ohec@hirakata.kmu.ac.jp
1 Histopathology Core Facility, Faculty of Medicine, Niigata University, Niigata 951-8510, Japan; riuko@med.niigata-u.ac.jp (R.O.); ajioka@med.niigata-u.ac.jp (Y.A.)
12 Division of Pathology, Niigata University Medical & Dental Hospital, Niigata 951-8520, Japan; umezu@med.niigata-u.ac.jp
7 Department of Pathology, Niigata Cancer Center Hospital, Niigata 951-8566, Japan; takawa@niigata-cc.jp
15 Department of Pathology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
8 Department of Pathology, Tachikawa General Hospital, Nagaoka, Niigata 940-8621, Japan; h-kobayashi15@tatikawa.or.jp
13 Department of Anatomic Pathology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8575, Japan; ffujishima@patholo2.med.tohoku.ac.jp
9 Department of Pathology, Gifu University Hospital, Gifu 501-1194, Japan; hern@live.jp (K.K
AuthorAffiliation_xml – name: 14 Cancer Genomics Unit, Clinical Genomics Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan; befurusato@me.com
– name: 1 Histopathology Core Facility, Faculty of Medicine, Niigata University, Niigata 951-8510, Japan; riuko@med.niigata-u.ac.jp (R.O.); ajioka@med.niigata-u.ac.jp (Y.A.)
– name: 3 Division of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan
– name: 10 Department of Pathology, Niigata City General Hospital, Niigata 950-1197, Japan; shibuya2u@hosp.niigata.niigata.jp
– name: 9 Department of Pathology, Gifu University Hospital, Gifu 501-1194, Japan; hern@live.jp (K.K.); tats_m@gifu-u.ac.jp (T.M.)
– name: 11 Department of Diagnostic Pathology, Nagaoka Red Cross Hospital, Nagaoka, Niigata 940-2085, Japan; usuda@nagaoka.jrc.or.jp
– name: 17 Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi 780-8562, Japan; kurochankochi@yahoo.co.jp
– name: 6 Department of Pathology, Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka 430-8558, Japan; otsuki@sis.seirei.or.jp
– name: 18 Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Aichi 480-1195, Japan; tsuzuki@aichi-med-u.ac.jp
– name: 2 Department of Pathology and Molecular Pathology, University and University Hospital Zurich, CH-8091 Zurich, Switzerland; Peter.Schraml@usz.ch (P.S.); Silvia.Angori@usz.ch (S.A.); Aashil.Batavia@usz.ch (A.A.B.)
– name: 19 Department of Surgical Pathology, Tokyo Women’s Medical University Hospital, Shinjuku-ku, Tokyo 162-8666, Japan; nagashima.yoji@twmu.ac.jp
– name: 15 Department of Pathology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
– name: 16 Department of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, Yahaba-cho, Shiwa-gun, Iwate 028-3695, Japan; mosakabe@iwate-med.ac.jp (M.O.); tsugai@iwate-med.ac.jp (T.S.)
– name: 7 Department of Pathology, Niigata Cancer Center Hospital, Niigata 951-8566, Japan; takawa@niigata-cc.jp
– name: 12 Division of Pathology, Niigata University Medical & Dental Hospital, Niigata 951-8520, Japan; umezu@med.niigata-u.ac.jp
– name: 8 Department of Pathology, Tachikawa General Hospital, Nagaoka, Niigata 940-8621, Japan; h-kobayashi15@tatikawa.or.jp
– name: 4 Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland
– name: 5 Department of Pathology and Laboratory Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan; ohec@hirakata.kmu.ac.jp
– name: 13 Department of Anatomic Pathology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8575, Japan; ffujishima@patholo2.med.tohoku.ac.jp
Author_xml – sequence: 1
  givenname: Riuko
  orcidid: 0000-0001-5820-7870
  surname: Ohashi
  fullname: Ohashi, Riuko
– sequence: 2
  givenname: Peter
  surname: Schraml
  fullname: Schraml, Peter
– sequence: 3
  givenname: Silvia
  surname: Angori
  fullname: Angori, Silvia
– sequence: 4
  givenname: Aashil A.
  surname: Batavia
  fullname: Batavia, Aashil A.
– sequence: 5
  givenname: Niels J.
  surname: Rupp
  fullname: Rupp, Niels J.
– sequence: 6
  givenname: Chisato
  surname: Ohe
  fullname: Ohe, Chisato
– sequence: 7
  givenname: Yoshiro
  orcidid: 0000-0002-0568-3811
  surname: Otsuki
  fullname: Otsuki, Yoshiro
– sequence: 8
  givenname: Takashi
  orcidid: 0000-0003-3972-9889
  surname: Kawasaki
  fullname: Kawasaki, Takashi
– sequence: 9
  givenname: Hiroshi
  surname: Kobayashi
  fullname: Kobayashi, Hiroshi
– sequence: 10
  givenname: Kazuhiro
  orcidid: 0000-0002-5390-8966
  surname: Kobayashi
  fullname: Kobayashi, Kazuhiro
– sequence: 11
  givenname: Tatsuhiko
  orcidid: 0000-0002-4750-2046
  surname: Miyazaki
  fullname: Miyazaki, Tatsuhiko
– sequence: 12
  givenname: Hiroyuki
  orcidid: 0000-0002-3052-2358
  surname: Shibuya
  fullname: Shibuya, Hiroyuki
– sequence: 13
  givenname: Hiroyuki
  surname: Usuda
  fullname: Usuda, Hiroyuki
– sequence: 14
  givenname: Hajime
  surname: Umezu
  fullname: Umezu, Hajime
– sequence: 15
  givenname: Fumiyoshi
  surname: Fujishima
  fullname: Fujishima, Fumiyoshi
– sequence: 16
  givenname: Bungo
  surname: Furusato
  fullname: Furusato, Bungo
– sequence: 17
  givenname: Mitsumasa
  orcidid: 0000-0002-1797-3189
  surname: Osakabe
  fullname: Osakabe, Mitsumasa
– sequence: 18
  givenname: Tamotsu
  surname: Sugai
  fullname: Sugai, Tamotsu
– sequence: 19
  givenname: Naoto
  surname: Kuroda
  fullname: Kuroda, Naoto
– sequence: 20
  givenname: Toyonori
  surname: Tsuzuki
  fullname: Tsuzuki, Toyonori
– sequence: 21
  givenname: Yoji
  surname: Nagashima
  fullname: Nagashima, Yoji
– sequence: 22
  givenname: Yoichi
  surname: Ajioka
  fullname: Ajioka, Yoichi
– sequence: 23
  givenname: Holger
  surname: Moch
  fullname: Moch, Holger
BookMark eNpdkc1r3DAQxUVJaNJkz70KeullG33ZWl0KxSRpYEkgH2cx1o7XDrbkSnZh-9dHYZeSRAfNgH56M7z3hRz54JGQr5z9kNKwCwfeYUycc8aVEZ_IqWBaLMvSqKM3_QlZpPTM8pGS61J_JieSl0JKpU_Jv6qHlDpHqzaGIYxtqJHeo4eeVtjnC6LrfBiA3ng3Rwp0DXGLkd7OQ51LaA4_U2Z6ug4pYaKPLXj6gOhp5-nUIr0MKauMbdfnUQ9zPe1GPCfHDfQJF4d6Rp6uLh-r38v13fVN9Wu9dKpU03LFhGt0w1htjCkKXMmaFyBlUzRCQKHAIFdsw4xTm1pIwXXRmJrjipUguJPyjPzc645zPeDGoZ8i9HaM3QBxZwN09v2L71q7DX9tuRKl4joLfD8IxPBnxjTZoUsuuwMew5yskExzyQxnGf32AX0Oc8xuZqpQWhmjjMrUxZ5yMfsVsfm_DGf2NVr7IVr5AqZ0mM4
CitedBy_id crossref_primary_10_1007_s00292_021_00979_w
crossref_primary_10_1016_j_pathol_2022_09_002
crossref_primary_10_3390_cancers12020521
crossref_primary_10_3390_cancers12020465
crossref_primary_10_1016_j_pathol_2020_09_015
crossref_primary_10_3390_medicines7080044
crossref_primary_10_1007_s00428_022_03283_x
crossref_primary_10_1038_s41379_021_00906_7
crossref_primary_10_3390_biomedicines11112875
crossref_primary_10_1038_s41379_021_00896_6
crossref_primary_10_1016_j_humpath_2020_12_006
crossref_primary_10_1007_s00120_019_01108_5
crossref_primary_10_1016_j_urolonc_2021_04_042
crossref_primary_10_1002_gcc_22886
crossref_primary_10_1111_cas_14835
crossref_primary_10_1007_s00428_019_02710_w
crossref_primary_10_1038_s41379_021_00779_w
crossref_primary_10_1111_his_14700
crossref_primary_10_1111_iju_14648
crossref_primary_10_1016_j_modpat_2024_100467
crossref_primary_10_3390_cancers12010168
crossref_primary_10_1158_0008_5472_CAN_20_0754
crossref_primary_10_3390_ijms23052603
crossref_primary_10_1016_j_ajur_2021_11_010
Cites_doi 10.1097/00000478-200009000-00008
10.1002/path.1711550402
10.3233/KCA-160002
10.1002/gcc.10118
10.1136/jclinpath-2013-201895
10.1038/modpathol.3800286
10.1007/BF02890129
10.7554/eLife.23268
10.1097/PAS.0b013e31829a85d0
10.1093/hmg/ddm371
10.1136/jclinpath-2011-200339
10.1097/PAS.0000000000000456
10.1016/S0022-5347(01)66944-1
10.1038/bmt.2012.244
10.1155/2015/476508
10.1158/0008-5472.CAN-17-0986
10.1309/AJCPSATJTKBI6J4N
10.1097/00000478-199905000-00006
10.7326/0003-4819-140-7-200404060-00009
10.1097/00000478-199511000-00004
10.1097/PAS.0b013e3181831e68
10.1016/j.eururo.2016.02.029
10.1038/modpathol.2015.101
10.1016/j.tranon.2019.05.005
10.1038/modpathol.2016.133
10.4103/UA.UA_32_18
10.1111/his.13865
10.1080/08998280.2015.11929188
10.18632/oncotarget.11605
10.1016/j.ccr.2014.07.014
10.1016/j.humpath.2017.03.004
ContentType Journal Article
Copyright 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2019 by the authors. 2019
Copyright_xml – notice: 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2019 by the authors. 2019
DBID AAYXX
CITATION
3V.
7T5
7TO
7XB
8FE
8FH
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
GUQSH
H94
HCIFZ
LK8
M2O
M7P
MBDVC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.3390/cancers11101492
DatabaseName CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
Biological Sciences
ProQuest research library
Biological Science Database
Research Library (Corporate)
ProQuest Publicly Available Content database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2072-6694
ExternalDocumentID 10_3390_cancers11101492
GroupedDBID ---
3V.
53G
5VS
8FE
8FH
8G5
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ADBBV
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
ESX
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HCIFZ
HYE
IAO
IHR
KQ8
LK8
M2O
M48
M7P
MODMG
M~E
OK1
P6G
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RPM
TUS
7T5
7TO
7XB
8FK
H94
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c464t-802cf7f00b99955e83b15a33f5f22a54a9e140d09c4db232175f9b1e806a21c33
IEDL.DBID RPM
ISSN 2072-6694
IngestDate Tue Sep 17 21:09:38 EDT 2024
Sat Oct 05 05:34:36 EDT 2024
Thu Oct 10 22:15:11 EDT 2024
Fri Aug 23 04:53:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c464t-802cf7f00b99955e83b15a33f5f22a54a9e140d09c4db232175f9b1e806a21c33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-0568-3811
0000-0001-5820-7870
0000-0002-1797-3189
0000-0002-5390-8966
0000-0002-3052-2358
0000-0003-3972-9889
0000-0002-4750-2046
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826417/
PMID 31623347
PQID 2547499494
PQPubID 2032421
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6826417
proquest_miscellaneous_2307130910
proquest_journals_2547499494
crossref_primary_10_3390_cancers11101492
PublicationCentury 2000
PublicationDate 20191003
PublicationDateYYYYMMDD 2019-10-03
PublicationDate_xml – month: 10
  year: 2019
  text: 20191003
  day: 3
PublicationDecade 2010
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Cancers
PublicationYear 2019
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Chauveau (ref_16) 2004; 140
Quddus (ref_15) 2019; 11
Latham (ref_7) 1999; 23
Nagy (ref_20) 2002; 35
Paolella (ref_14) 2017; 6
ref_31
Crotty (ref_5) 1995; 154
Sun (ref_17) 2017; 77
ref_30
Davis (ref_13) 2014; 26
Algaba (ref_28) 2012; 65
Kouba (ref_27) 2016; 29
Podduturi (ref_24) 2015; 28
Kanda (ref_34) 2013; 48
Yip (ref_25) 2017; 1
Williamson (ref_10) 2017; 63
ref_21
Trpkov (ref_22) 2019; 75
Deml (ref_32) 2015; 39
Akhtar (ref_6) 1995; 19
Amin (ref_23) 2008; 32
Thoenes (ref_3) 1988; 155
Gasparre (ref_18) 2008; 17
Brunelli (ref_12) 2010; 133
ref_2
Tickoo (ref_8) 2000; 24
Ohashi (ref_26) 2019; 12
Noske (ref_33) 2017; 8
Ng (ref_9) 2014; 67
Yap (ref_4) 2015; 2015
Brunelli (ref_11) 2005; 18
Trpkov (ref_29) 2013; 37
Thoenes (ref_1) 1985; 48
Lang (ref_19) 2015; 28
References_xml – volume: 24
  start-page: 1247
  year: 2000
  ident: ref_8
  article-title: Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma
  publication-title: Am. J. Surg. Pathol.
  doi: 10.1097/00000478-200009000-00008
  contributor:
    fullname: Tickoo
– ident: ref_30
– volume: 155
  start-page: 277
  year: 1988
  ident: ref_3
  article-title: Chromophobe cell renal carcinoma and its variants—A report on 32 cases
  publication-title: J. Pathol.
  doi: 10.1002/path.1711550402
  contributor:
    fullname: Thoenes
– volume: 1
  start-page: 41
  year: 2017
  ident: ref_25
  article-title: Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)
  publication-title: Kidney Cancer
  doi: 10.3233/KCA-160002
  contributor:
    fullname: Yip
– volume: 35
  start-page: 256
  year: 2002
  ident: ref_20
  article-title: Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.10118
  contributor:
    fullname: Nagy
– volume: 67
  start-page: 97
  year: 2014
  ident: ref_9
  article-title: Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): Can novel molecular biomarkers help solve an old problem?
  publication-title: J. Clin. Pathol.
  doi: 10.1136/jclinpath-2013-201895
  contributor:
    fullname: Ng
– volume: 18
  start-page: 161
  year: 2005
  ident: ref_11
  article-title: Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10 and 17, and this pattern of genetic abnormality is not present in renal oncocytoma
  publication-title: Mod. Pathol.
  doi: 10.1038/modpathol.3800286
  contributor:
    fullname: Brunelli
– volume: 48
  start-page: 207
  year: 1985
  ident: ref_1
  article-title: Human chromophobe cell renal carcinoma
  publication-title: Virchows Arch. B
  doi: 10.1007/BF02890129
  contributor:
    fullname: Thoenes
– volume: 6
  start-page: e23268
  year: 2017
  ident: ref_14
  article-title: Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability
  publication-title: Elife
  doi: 10.7554/eLife.23268
  contributor:
    fullname: Paolella
– volume: 37
  start-page: 1505
  year: 2013
  ident: ref_29
  article-title: Handling and staging of renal cell carcinoma: The International Society of Urological Pathology Consensus (ISUP) conference recommendations
  publication-title: Am. J. Surg. Pathol.
  doi: 10.1097/PAS.0b013e31829a85d0
  contributor:
    fullname: Trpkov
– volume: 17
  start-page: 986
  year: 2008
  ident: ref_18
  article-title: Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddm371
  contributor:
    fullname: Gasparre
– volume: 65
  start-page: 106
  year: 2012
  ident: ref_28
  article-title: Handling and reporting of nephrectomy specimens for adult renal tumours: A survey by the European Network of Uropathology
  publication-title: J. Clin. Pathol.
  doi: 10.1136/jclinpath-2011-200339
  contributor:
    fullname: Algaba
– volume: 39
  start-page: 889
  year: 2015
  ident: ref_32
  article-title: Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma
  publication-title: Am. J. Surg. Pathol.
  doi: 10.1097/PAS.0000000000000456
  contributor:
    fullname: Deml
– volume: 154
  start-page: 964
  year: 1995
  ident: ref_5
  article-title: Chromophobe cell renal carcinoma: Clinicopathological features of 50 cases
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(01)66944-1
  contributor:
    fullname: Crotty
– ident: ref_21
– volume: 48
  start-page: 452
  year: 2013
  ident: ref_34
  article-title: Investigation of the freely-available easy-to-use software “EZR” (Easy R) for medical statistics
  publication-title: Bone Marrow Transplant.
  doi: 10.1038/bmt.2012.244
  contributor:
    fullname: Kanda
– volume: 2015
  start-page: 476508
  year: 2015
  ident: ref_4
  article-title: Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms
  publication-title: Biomed. Res. Int.
  doi: 10.1155/2015/476508
  contributor:
    fullname: Yap
– volume: 77
  start-page: 5313
  year: 2017
  ident: ref_17
  article-title: HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-17-0986
  contributor:
    fullname: Sun
– volume: 133
  start-page: 116
  year: 2010
  ident: ref_12
  article-title: Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: A validation study combining metaphase and interphase analyses
  publication-title: Am. J. Clin. Pathol.
  doi: 10.1309/AJCPSATJTKBI6J4N
  contributor:
    fullname: Brunelli
– ident: ref_31
– volume: 23
  start-page: 530
  year: 1999
  ident: ref_7
  article-title: Subtypes of chromophobe cell renal carcinoma: An ultrastructural and histochemical study of 13 cases
  publication-title: Am. J. Surg. Pathol.
  doi: 10.1097/00000478-199905000-00006
  contributor:
    fullname: Latham
– volume: 140
  start-page: 510
  year: 2004
  ident: ref_16
  article-title: Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-140-7-200404060-00009
  contributor:
    fullname: Chauveau
– volume: 19
  start-page: 1245
  year: 1995
  ident: ref_6
  article-title: Chromophobe cell carcinoma of the kidney. A clinicopathologic study of 21 cases
  publication-title: Am. J. Surg. Pathol.
  doi: 10.1097/00000478-199511000-00004
  contributor:
    fullname: Akhtar
– volume: 32
  start-page: 1822
  year: 2008
  ident: ref_23
  article-title: Chromophobe renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases
  publication-title: Am. J. Surg. Pathol.
  doi: 10.1097/PAS.0b013e3181831e68
  contributor:
    fullname: Amin
– ident: ref_2
  doi: 10.1016/j.eururo.2016.02.029
– volume: 28
  start-page: 1458
  year: 2015
  ident: ref_19
  article-title: Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors
  publication-title: Mod. Pathol.
  doi: 10.1038/modpathol.2015.101
  contributor:
    fullname: Lang
– volume: 12
  start-page: 1131
  year: 2019
  ident: ref_26
  article-title: Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma
  publication-title: Transl. Oncol.
  doi: 10.1016/j.tranon.2019.05.005
  contributor:
    fullname: Ohashi
– volume: 29
  start-page: 1347
  year: 2016
  ident: ref_27
  article-title: High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: Implications for tumor clonal evolution and treatment
  publication-title: Mod. Pathol.
  doi: 10.1038/modpathol.2016.133
  contributor:
    fullname: Kouba
– volume: 11
  start-page: 6
  year: 2019
  ident: ref_15
  article-title: Chromosomal aberrations in renal cell carcinoma: An overview with implications for clinical practice
  publication-title: Urol. Ann.
  doi: 10.4103/UA.UA_32_18
  contributor:
    fullname: Quddus
– volume: 75
  start-page: 174
  year: 2019
  ident: ref_22
  article-title: Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): A distinct entity?
  publication-title: Histopathology
  doi: 10.1111/his.13865
  contributor:
    fullname: Trpkov
– volume: 28
  start-page: 57
  year: 2015
  ident: ref_24
  article-title: Eosinophilic variant of chromophobe renal cell carcinoma
  publication-title: Proc. Bayl. Univ. Med. Cent.
  doi: 10.1080/08998280.2015.11929188
  contributor:
    fullname: Podduturi
– volume: 8
  start-page: 14794
  year: 2017
  ident: ref_33
  article-title: Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11605
  contributor:
    fullname: Noske
– volume: 26
  start-page: 319
  year: 2014
  ident: ref_13
  article-title: The somatic genomic landscape of chromophobe renal cell carcinoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.07.014
  contributor:
    fullname: Davis
– volume: 63
  start-page: 149
  year: 2017
  ident: ref_10
  article-title: Diagnostic criteria for oncocytic renal neoplasms: A survey of urologic pathologists
  publication-title: Hum. Pathol.
  doi: 10.1016/j.humpath.2017.03.004
  contributor:
    fullname: Williamson
SSID ssj0000331767
Score 2.3715987
Snippet Chromophobe renal cell carcinoma (chRCC) is a renal tumor subtype with a good prognosis, characterized by multiple chromosomal copy number variations (CNV)....
SourceID pubmedcentral
proquest
crossref
SourceType Open Access Repository
Aggregation Database
StartPage 1492
SubjectTerms Cell membranes
Chromosome 1
Copy number
Cytoplasm
Genomes
Genomic instability
Genotype & phenotype
Genotypes
Kidney cancer
Leukocytes (eosinophilic)
Medical prognosis
Mitochondrial DNA
Mutation
Phenotypes
Regression analysis
Renal cell carcinoma
Sex chromosomes
Tumors
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9tAEB5aB0ovIWlS6rzYQg-9iEj70FqnkASHUBJT0gRyE6vVLjYkWseyL_n1mZHXTt1DLzpoXzCzO_PNgxmAHw5Rr1FeJVZqkUhem2Tg8yzRxqZ1KoSSXTGd21F-_SB_ParH6HBrY1rlSiZ2groOlnzkp2jIaETnspBn05eEukZRdDW20PgIWxwtBd6DrYvh6Pfd2suCp2U618uaPgLt-1NLxJy1-MTJOOCb6ugdY25mSP6lcq52YDtiRXa-ZO4ufHDNF_h0G6Phe_DadbScWEYVbp_DdBwqx-4crbl0T_ihPkFNeDYMpcBixgy7obzvGRt1bUBY8HFli3Oe2E2gADC7H5uG_UHzlk0ahvCQDUOLu0zJ82IZChry2u7Dw9Xw_vI6ib0UkAm5nKMi4tZrn6YVIkKl3EBUmTJCeOU5N0qawiEB67Swsq4QZSGq8EWVuUGaG55ZIb5CrwmN-wbMm8rgTyF1hepfcuOkdbiFR1EprJR9-LkiaTldlswo0dQg6pf_UL8PRyuSl_HttOU7p_vwfT2Mt55CGaZxYYFzBFnXhHX6oDdYtT6S6mZvjjSTcVc_O0eTSmb64P-HH8JnBEdFl7gnjqA3ny3cMQKQeXUSb9kbZvjfUA
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access(OpenAccess)
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LS8NAEF6kgngRn1itsoIHL9FkH0lzEJFiKdL2oC30FjbbXVpok5q2oP56Z9K0tdKDlxz2MYHZ3Znv2x1mCLk1gHqVtNLRIuCOYH3lVK3vOYHSbt_lXIo8mU6r7Te64rUne-tyQIUCp1upHdaT6maj-8-Pryc48I_IOIGyP2jUTzaFU4t4H-zxLsOsXBjHV2D93CxzcJV5RVnmBszx_VAsUv1sk7HppdbQczNw8pcnqh-SgwJC0ufFmh-RHZMck71W8Uh-Qr7zQpdDTTHx7TidDNLY0DeDc2pmBB8sH5SkY0XBOMwzqmgTw8Ez2s6rg9DUFjOnMGZEmym-C9POQCX0HVgvHSYUUCN9SacgZYIXMpqC_cHL3FPSrb90ag2nKLEAa-OLGfgnpm1gXTcGoCilqfLYk4pzKy1jSgoVGmBgfTfUoh8D-AKwYcPYM1XXV8zTnJ-RUpIm5pxQq2IFjVwEMaACwZQR2oAICxaUayHK5G6p0miyyKQRAQNB7Ud_tF8mlaXKo-WOiIDJBkDPRAiSblbdcBjwhUMlJp3DGI6kGyFQmQQbS7X6JabT3uxJhoM8rbYPTEt4wcU_pF-SfQBOYR7UxyukNMvm5grAySy-zjfdDz_G5YM
  priority: 102
  providerName: Scholars Portal
Title Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype
URI https://www.proquest.com/docview/2547499494
https://search.proquest.com/docview/2307130910
https://pubmed.ncbi.nlm.nih.gov/PMC6826417
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV09b9swED3EKVB0KZq0RZ2mBgN06KJYEknJGlvDaVDERpAmgDeBpEnYgE0Z_lj66_soy6ndMQsH8UPC8ch7jzzdEX21QL1KOhkZkfNIpBMV9VyWRLky8STmXIo6mM5wlN0-iV9jOT4huf8XpnbaN3p27eeLaz-b1r6Vy4Xp7v3EuvfDfgZMLJK826IWFPSAotfbL4dJzPJdGB8OSt81QX6rNVZ14AMhfw1PYPV5SKlyaIz-Icxj_8gDg3Pzjt42SJF9333RGZ1Yf06vh81d-Hv6U-eznBkW4tsuquW00pY92NCnb-coQpYgXy0Uwx6wXTHF7oLX94qN6iQgrHJNzzXazNldFa5_2eNUefYb5JbNPAM4ZINqjVGW4dzFMGwz4cz2Az3dDB77t1GTSQFTkIkNzFBqXO7iWAMPSml7XCdSce6kS1MlhSosiNYkLoyYaGAsYApX6MT24kylieH8I536yttPxJzSCg8hPA3jL1JlhbEYwmGj5EaINn3bi7Rc7gJmlCAaYSLK_yaiTZd7kZfNylmXIKw5WJgoMNLVczV0PlxkKG-rLdrwwK0D0mlTfjRVz68MUbOPa6BMdfTsRnkuXtzzM70Baipqjz5-Saeb1dZ-ATLZ6A69-jEY3T90qPVznKAcil6n1s6_oArqLw
link.rule.ids 230,315,730,783,787,888,2228,21402,24332,27938,27939,33758,33759,43819,53806,53808,74638
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9swDCa2Fth2GbpuQ7M-pgE97GLUtiQrPg1tkSLdkqBoU6A3Q5YlJEBrZXFy2a8v6SjpssMuPlgvgJTIjw-QAKcWUa-WTkZGKB6JtNJR12VJpLSJq5hzKdpiOsNR1r8XPx_kQ3C4NSGtci0TW0FdeUM-8jM0ZBSic5GLH7PfEXWNouhqaKHxGnapVBXe6t2L3ujmduNlwdMSlalVTR-O9v2ZIWLOG3ziZByk2-roBWNuZ0j-pXKu9uB9wIrsfMXcD_DK1vvwZhii4R_hT9vRcmoYVbh98rOJLy27tbTm0j7ih_oE1f5JM5QCyznTbEB533M2atuAMO_CygbnPLKBpwAwG090ze7QvGXTmiE8ZD3f4C4z8rwYhoKGvLaf4P6qN77sR6GXAjIhEwtURKlxysVxiYhQStvlZSI15066NNVS6NyiqVXFuRFViSgLUYXLy8R240ynieH8M-zUvrYHwJwuNf7kQpWo_kWqrTAWt3AoKrkRogPf1yQtZquSGQWaGkT94h_qd-BoTfIivJ2meOF0B75thvHWUyhD19YvcQ4n65qwTgfUFqs2R1Ld7O2Rejpp62dnaFKJRH35_-Ff4W1_PBwUg-vRr0N4h0Apb5P4-BHsLOZLe4xgZFGehBv3DCZu4ko
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9swDCa6FCh2KbZuw9J2mwbs0IsR25Ks-DRsXYK2S4OiD6A3Q5YlJEBrpXFy6a8f6SjpssMuPlgvgJSo7xMJEuCbRdSrpZOREYpHIq101HdZEilt4irmXIo2mc7lODu7Exf38j7EPzUhrHJtE1tDXXlDb-Q9JDIK0bnIRc-FsIirX8Pvs6eIKkiRpzWU03gFu0rgrurA7s_B-Op68-KCKycqU6v8Phy5fs-QYOcNHnciCun21fSCN7ejJf-6foZvYD_gRvZjpei3sGPrA9i7DJ7xd_DcVrecGkbZbh_9bOJLy64tjTm1D_ihmkG1f9QMLcJyzjQbUQz4nI3bkiDMuzCywT4PbOTJGcxuJ7pmN0h12bRmCBXZwDc4y4xeYQxDo0MvuO_hbji4PT2LQl0FVEgmFngppcYpF8clokMpbZ-XidScO-nSVEuhc4u0q4pzI6oSERciDJeXie3HmU4Tw_kH6NS-th-BOV1q_MmFKhEKiFRbYSxO4dBsciNEF07WIi1mq_QZBdIOkn7xj_S7cLwWeRHOUVO8aL0LXzfNeALIraFr65fYhxPTJtzTBbWlqs2SlEN7u6WeTtpc2hnSK5Gow_8v_gX2cLMVo_Px7yN4jZgpb-P5-DF0FvOl_YS4ZFF-DhvuD2bh5n4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Classic+Chromophobe+Renal+Cell+Carcinoma+Incur+a+Larger+Number+of+Chromosomal+Losses+Than+Seen+in+the+Eosinophilic+Subtype&rft.jtitle=Cancers&rft.au=Ohashi%2C+Riuko&rft.au=Schraml%2C+Peter&rft.au=Angori%2C+Silvia&rft.au=Batavia%2C+Aashil+A&rft.date=2019-10-03&rft.issn=2072-6694&rft.eissn=2072-6694&rft.volume=11&rft.issue=10&rft_id=info:doi/10.3390%2Fcancers11101492&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6694&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6694&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6694&client=summon